TG THERAPEUTICS, INC. Stock-Based Compensation
TG THERAPEUTICS, INC. (TGTX) reported Stock-Based Compensation of $47.83 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- TG THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $27.88M, a 70.37% increase year-over-year.
- TG THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $19.95M, a 33.25% increase year-over-year.
- TG THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $15.65M, a 30.99% increase year-over-year.
- TG THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $17.69M, a 50.23% increase year-over-year.
- TG THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $64.67M, a 52.02% increase from fiscal 2024.
- TG THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $42.54M, a 12.15% increase from fiscal 2023.
- TG THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $37.93M, a 15.07% decline from fiscal 2022.
- TG THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $44.66M, a 27.11% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 1 month | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 13 month | Share-based Payment Arrangement, Noncash Expense 15 month | Share-based Payment Arrangement, Noncash Expense 16 month | Share-based Payment Arrangement, Noncash Expense 18 month | Share-based Payment Arrangement, Noncash Expense 19 month | Share-based Payment Arrangement, Noncash Expense 22 month | Share-based Payment Arrangement, Noncash Expense 25 month | Share-based Payment Arrangement, Noncash Expense 28 month | Share-based Payment Arrangement, Noncash Expense 119 month | Share-based Payment Arrangement, Noncash Expense 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $47.83M 10-Q · filed 2026-08-05 | $63.48M derived: sum of 3 quarters · filed 2026-08-05 | $81.16M derived: sum of 4 quarters · filed 2026-08-05 | |||||||||||||||
| 2026-03-31 | $19.95M 10-Q · filed 2026-05-06 | $35.60M derived: sum of 2 quarters · filed 2026-05-06 | $53.29M derived: sum of 3 quarters · filed 2026-05-06 | $69.65M derived: sum of 4 quarters · filed 2026-08-05 | |||||||||||||||
| 2025-12-31 | $15.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $33.34M derived: sum of 2 quarters · filed 2026-02-27 | $49.70M derived: sum of 3 quarters · filed 2026-08-05 | $64.67M 10-K · filed 2026-02-27 | |||||||||||||||
| 2025-09-30 | $17.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $34.05M derived: sum of 2 quarters · filed 2026-08-05 | $49.02M 10-Q · filed 2025-11-05 | $60.97M derived: sum of 4 quarters · filed 2026-08-05 | |||||||||||||||
| 2025-06-30 | $16.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $31.33M 10-Q · filed 2026-08-05 | $43.28M derived: sum of 3 quarters · filed 2026-08-05 | $55.05M derived: sum of 4 quarters · filed 2026-08-05 | |||||||||||||||
| 2025-03-31 | $14.97M 10-Q · filed 2026-05-06 | $26.92M derived: sum of 2 quarters · filed 2026-05-06 | $38.69M derived: sum of 3 quarters · filed 2026-05-06 | $48.17M derived: sum of 4 quarters · filed 2026-05-06 | |||||||||||||||
| 2024-12-31 | $11.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $23.72M derived: sum of 2 quarters · filed 2026-02-27 | $33.20M derived: sum of 3 quarters · filed 2026-02-27 | $42.54M 10-K · filed 2026-02-27 | |||||||||||||||
| 2024-09-30 | $11.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $21.25M derived: sum of 2 quarters · filed 2025-11-05 | $30.59M 10-Q · filed 2025-11-05 | $39.98M derived: sum of 4 quarters · filed 2026-02-27 | |||||||||||||||
| 2024-06-30 | $9.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $18.82M 10-Q · filed 2025-08-08 | $28.20M derived: sum of 3 quarters · filed 2026-02-27 | $37.39M derived: sum of 4 quarters · filed 2026-02-27 | |||||||||||||||
| 2024-03-31 | $9.34M 10-Q · filed 2025-05-09 | $18.72M derived: sum of 2 quarters · filed 2026-02-27 | $27.91M derived: sum of 3 quarters · filed 2026-02-27 | $40.45M derived: sum of 4 quarters · filed 2026-02-27 | |||||||||||||||
| 2023-12-31 | $9.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $18.57M derived: sum of 2 quarters · filed 2026-02-27 | $31.11M derived: sum of 3 quarters · filed 2026-02-27 | $37.93M 10-K · filed 2026-02-27 | |||||||||||||||
| 2023-09-30 | $9.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $21.73M derived: sum of 2 quarters · filed 2024-11-07 | $28.55M 10-Q · filed 2024-11-07 | $65.08M derived: sum of 4 quarters · filed 2025-03-03 | |||||||||||||||
| 2023-06-30 | $12.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $19.36M 10-Q · filed 2024-08-09 | $55.89M derived: sum of 3 quarters · filed 2025-03-03 | $62.89M derived: sum of 4 quarters · filed 2025-03-03 | |||||||||||||||
| 2023-03-31 | $6.82M 10-Q · filed 2024-05-06 | $43.35M derived: sum of 2 quarters · filed 2025-03-03 | $50.35M derived: sum of 3 quarters · filed 2025-03-03 | $49.35M derived: sum of 4 quarters · filed 2025-03-03 | |||||||||||||||
| 2022-12-31 | $36.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $43.53M derived: sum of 2 quarters · filed 2025-03-03 | $42.53M derived: sum of 3 quarters · filed 2025-03-03 | $44.66M 10-K · filed 2025-03-03 | $19.18M 10-K · filed 2023-03-01 | ||||||||||||||
| 2022-09-30 | $7.00M 10-Q · filed 2022-11-09 | $6.00M derived: sum of 2 quarters · filed 2022-11-09 | $8.13M 10-Q · filed 2023-11-06 | $22.48M derived: sum of 4 quarters · filed 2024-02-29 | |||||||||||||||
| 2022-06-30 | -$1.00M 10-Q · filed 2022-08-09 | $1.15M 10-Q · filed 2023-08-04 | $15.48M derived: sum of 3 quarters · filed 2024-02-29 | $29.48M derived: sum of 4 quarters · filed 2024-02-29 | |||||||||||||||
| 2022-03-31 | $2.12M 10-Q · filed 2023-05-08 | $16.48M derived: sum of 2 quarters · filed 2024-02-29 | $30.48M derived: sum of 3 quarters · filed 2024-02-29 | $46.78M derived: sum of 4 quarters · filed 2024-02-29 | |||||||||||||||
| 2021-12-31 | $14.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $28.36M derived: sum of 2 quarters · filed 2024-02-29 | $44.66M derived: sum of 3 quarters · filed 2024-02-29 | $61.27M 10-K · filed 2024-02-29 | |||||||||||||||
| 2021-09-30 | $14.00M 10-Q · filed 2022-11-09 | $30.30M derived: sum of 2 quarters · filed 2022-11-09 | $46.92M 10-Q · filed 2022-11-09 | $80.44M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||||||
| 2021-06-30 | $16.30M 10-Q · filed 2022-08-09 | $32.92M 10-Q · filed 2022-08-09 | $66.44M derived: sum of 3 quarters · filed 2023-03-01 | $94.74M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||||||
| 2021-03-31 | $16.62M 10-Q · filed 2022-05-10 | $50.14M derived: sum of 2 quarters · filed 2023-03-01 | $78.44M derived: sum of 3 quarters · filed 2023-03-01 | $85.84M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||||||
| 2020-12-31 | $33.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $61.82M derived: sum of 2 quarters · filed 2023-03-01 | $69.22M derived: sum of 3 quarters · filed 2023-03-01 | $80.29M 10-K · filed 2023-03-01 | |||||||||||||||
| 2020-09-30 | $28.30M 10-Q · filed 2021-11-08 | $28.33M 10-Q · filed 2020-11-09 | $35.70M derived: sum of 2 quarters · filed 2021-11-08 | $46.77M 10-Q · filed 2021-11-08 | $52.39M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||||
| 2020-06-30 | $7.40M 10-Q · filed 2021-08-06 | $7.37M 10-Q · filed 2020-08-10 | $18.44M 10-Q · filed 2021-08-06 | $24.09M derived: sum of 3 quarters · filed 2022-03-01 | $26.16M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||||
| 2020-03-31 | $11.07M 10-Q · filed 2021-05-10 | $16.69M derived: sum of 2 quarters · filed 2022-03-01 | $18.76M derived: sum of 3 quarters · filed 2022-03-01 | $20.52M derived: sum of 4 quarters · filed 2022-03-01 | |||||||||||||||
| 2019-12-31 | $5.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $7.70M derived: sum of 2 quarters · filed 2022-03-01 | $9.45M derived: sum of 3 quarters · filed 2022-03-01 | $11.34M 10-K · filed 2022-03-01 | $7.80M 10-K · filed 2020-03-02 | ||||||||||||||
| 2019-09-30 | $2.08M 10-Q · filed 2019-11-12 | $3.83M derived: sum of 2 quarters · filed 2019-11-12 | $5.71M 10-Q · filed 2020-11-09 | $7.17M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||
| 2019-06-30 | $1.76M 10-Q · filed 2019-08-09 | $3.64M 10-Q · filed 2020-08-10 | $5.10M derived: sum of 3 quarters · filed 2021-03-01 | $4.92M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||
| 2019-03-31 | $1.88M 10-Q · filed 2020-05-11 | $3.34M derived: sum of 2 quarters · filed 2021-03-01 | $3.17M derived: sum of 3 quarters · filed 2021-03-01 | $7.43M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||
| 2018-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.28M derived: sum of 2 quarters · filed 2021-03-01 | $5.55M derived: sum of 3 quarters · filed 2021-03-01 | $12.89M 10-K · filed 2021-03-01 | $12.90M 10-K · filed 2019-03-01 | ||||||||||||||
| 2018-09-30 | -$173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $4.09M derived: sum of 2 quarters · filed 2019-11-12 | $11.43M 10-Q · filed 2019-11-12 | $14.95M derived: sum of 4 quarters · filed 2020-03-02 | |||||||||||||||
| 2018-06-30 | $4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $11.60M 10-Q · filed 2019-08-09 | $15.13M derived: sum of 3 quarters · filed 2020-03-02 | $20.02M derived: sum of 4 quarters · filed 2020-03-02 | |||||||||||||||
| 2018-03-31 | $7.34M 10-Q · filed 2019-05-10 | $10.86M derived: sum of 2 quarters · filed 2020-03-02 | $15.75M derived: sum of 3 quarters · filed 2020-03-02 | $17.24M derived: sum of 4 quarters · filed 2020-03-02 | |||||||||||||||
| 2017-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $8.41M derived: sum of 2 quarters · filed 2020-03-02 | $9.90M derived: sum of 3 quarters · filed 2020-03-02 | $15.90M 10-K · filed 2020-03-02 | $15.95M 10-K · filed 2018-03-15 | ||||||||||||||
| 2017-09-30 | $4.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $6.38M derived: sum of 2 quarters · filed 2018-11-09 | $12.38M 10-Q · filed 2018-11-09 | $12.38M 10-Q · filed 2017-11-09 | $13.69M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||||
| 2017-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $7.49M 10-Q · filed 2018-08-09 | $7.49M 10-Q · filed 2017-08-09 | $8.80M derived: sum of 3 quarters · filed 2019-03-01 | $11.60M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||||
| 2017-03-31 | $5.13M 10-K · filed 2020-03-02 | $6.00M 10-Q · filed 2018-05-10 | $6.00M 10-Q · filed 2017-05-10 | $7.31M derived: sum of 2 quarters · filed 2019-03-01 | $10.11M derived: sum of 3 quarters · filed 2019-03-01 | $11.71M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||
| 2016-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $4.12M derived: sum of 2 quarters · filed 2019-03-01 | $5.72M derived: sum of 3 quarters · filed 2019-03-01 | $7.50M 10-K · filed 2019-03-01 | $7.51M 10-K · filed 2017-03-16 | ||||||||||||||
| 2016-09-30 | $2.80M 10-Q · filed 2016-11-09 | $4.40M derived: sum of 2 quarters · filed 2016-11-09 | $6.18M 10-Q · filed 2017-11-09 | $8.96M derived: sum of 4 quarters · filed 2018-03-15 | |||||||||||||||
| 2016-06-30 | $1.60M 10-Q · filed 2016-08-09 | $3.35M 10-Q · filed 2017-08-09 | $6.16M derived: sum of 3 quarters · filed 2018-03-15 | $7.36M derived: sum of 4 quarters · filed 2018-03-15 | |||||||||||||||
| 2016-03-31 | $1.70M 10-Q · filed 2017-05-10 | $4.56M derived: sum of 2 quarters · filed 2018-03-15 | $5.76M derived: sum of 3 quarters · filed 2018-03-15 | $11.96M derived: sum of 4 quarters · filed 2018-03-15 | |||||||||||||||
| 2015-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $4.06M derived: sum of 2 quarters · filed 2018-03-15 | $10.26M derived: sum of 3 quarters · filed 2018-03-15 | $15.70M 10-K · filed 2018-03-15 | |||||||||||||||
| 2015-09-30 | $1.20M 10-Q · filed 2016-11-09 | $7.40M derived: sum of 2 quarters · filed 2016-11-09 | $12.84M 10-Q · filed 2016-11-09 | $17.80M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||||
| 2015-06-30 | $6.20M 10-Q · filed 2016-08-09 | $11.60M 10-Q · filed 2016-08-09 | $16.60M derived: sum of 3 quarters · filed 2017-03-16 | $20.69M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||||
| 2015-03-31 | $5.36M 10-Q · filed 2016-05-10 | $10.40M derived: sum of 2 quarters · filed 2017-03-16 | $14.49M derived: sum of 3 quarters · filed 2017-03-16 | $22.23M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||||
| 2014-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $9.14M derived: sum of 2 quarters · filed 2017-03-16 | $16.87M derived: sum of 3 quarters · filed 2017-03-16 | $21.11M 10-K · filed 2017-03-16 | |||||||||||||||
| 2014-09-30 | $4.10M 10-Q · filed 2014-11-14 | $11.84M derived: sum of 2 quarters · filed 2014-11-14 | $16.07M 10-Q · filed 2015-11-09 | $17.01M derived: sum of 4 quarters · filed 2016-03-15 | |||||||||||||||
| 2014-06-30 | $7.74M 10-Q · filed 2014-07-24 | $11.97M 10-Q · filed 2015-08-10 | $12.92M derived: sum of 3 quarters · filed 2016-03-15 | $13.91M derived: sum of 4 quarters · filed 2016-03-15 | |||||||||||||||
| 2014-03-31 | $4.23M 10-Q · filed 2015-05-11 | $5.18M derived: sum of 2 quarters · filed 2016-03-15 | $6.18M derived: sum of 3 quarters · filed 2016-03-15 | $7.55M derived: sum of 4 quarters · filed 2016-03-15 | $12.94M 10-Q · filed 2014-05-14 | ||||||||||||||
| 2013-12-31 | $947.15K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.94M derived: sum of 2 quarters · filed 2016-03-15 | $3.32M derived: sum of 3 quarters · filed 2016-03-15 | $5.20M 10-K · filed 2016-03-15 | $8.71M 10-K · filed 2014-03-07 | ||||||||||||||
| 2013-09-30 | $996.75K 10-Q · filed 2013-11-14 | $2.37M derived: sum of 2 quarters · filed 2013-11-14 | $4.26M 10-Q · filed 2014-11-14 | $5.50M derived: sum of 4 quarters · filed 2014-05-14 | $7.76M 10-Q · filed 2013-11-14 | ||||||||||||||
| 2013-06-30 | $1.37M 10-Q · filed 2013-08-09 | $3.26M 10-Q · filed 2014-07-24 | $4.50M derived: sum of 3 quarters · filed 2014-05-14 | $5.32M derived: sum of 4 quarters · filed 2014-05-14 | $6.77M 10-Q · filed 2013-08-09 | ||||||||||||||
| 2013-03-31 | $1.89M 10-Q · filed 2014-05-14 | $3.13M derived: sum of 2 quarters · filed 2014-05-14 | $3.95M derived: sum of 3 quarters · filed 2014-05-14 | $5.12M derived: sum of 4 quarters · filed 2014-05-14 | $5.39M 10-Q · filed 2013-05-14 | ||||||||||||||
| 2012-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $2.06M derived: sum of 2 quarters · filed 2014-03-07 | $3.23M derived: sum of 3 quarters · filed 2014-03-07 | $3.42M 10-K · filed 2014-03-07 | $3.51M 10-K · filed 2013-03-21 | ||||||||||||||
| 2012-09-30 | $818.09K 10-Q · filed 2012-11-14 | $1.99M derived: sum of 2 quarters · filed 2012-11-14 | $2.18M 10-Q · filed 2013-11-14 | $2.27M derived: sum of 4 quarters · filed 2013-05-14 | $2.27M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | $1.17M 10-Q/A · filed 2012-09-07 | $1.36M 10-Q · filed 2013-08-09 | $1.45M derived: sum of 3 quarters · filed 2013-05-14 | $1.43M derived: sum of 4 quarters · filed 2013-05-14 | $1.45M 10-Q/A · filed 2012-09-07 | ||||||||||||||
| 2012-03-31 | $188.51K 10-Q · filed 2013-05-14 | $275.00K derived: sum of 2 quarters · filed 2013-05-14 | $261.39K derived: sum of 3 quarters · filed 2013-05-14 | $275.00K 10-Q · filed 2012-05-14 | |||||||||||||||
| 2011-12-31 | $86.49K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $72.88K derived: sum of 2 quarters · filed 2013-03-21 | $86.49K 10-K · filed 2013-03-21 | ||||||||||||||||
| 2011-09-30 | -$13.61K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | $19.21K 10-Q · filed 2011-11-14 | $4.42M 10-Q · filed 2011-11-14 | |||||||||||||||
| 2011-06-30 | $13.61K 10-Q/A · filed 2011-09-14 | $4.41M 10-Q/A · filed 2011-09-14 | |||||||||||||||||
| 2010-09-30 | $5.63K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $211.77K 10-Q · filed 2011-11-14 | |||||||||||||||||
| 2010-06-30 | $206.14K 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |